Kamada Stock Executives


USD 4.58  0.07  1.55%   

Kamada employes about 355 people. The company is managed by 34 executives with a total tenure of roughly 223 years, averaging almost 6.0 years of service per executive having 10.44 employees per reported executive. Analysis of Kamada management performance can provide insight into the company performance. Note, employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with Kamada future performance.
Please see Correlation Analysis.
  Gil Efron  CEO
CFO, Principal Accounting Officer and Deputy CEO
  David Tsur  Chairman
Co-Founder and Deputy Executive Chairman
  Eran Schenker  President
Vice President - Medical Director

Kamada Return on Sales


Kamada Management Team Effectiveness

As of December 7, 2022, Return on Average Assets is expected to decline to -0.0092. In addition to that, Return on Average Equity is expected to decline to -0.01. Kamada Assets Non Current are projected to increase significantly based on the last few years of reporting. The past year's Assets Non Current were at 188.62 Million. The current year Tax Assets is expected to grow to about 1.3 M, whereas Total Assets are forecasted to decline to about 251.8 M. Kamada management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.
Kamada Weighted Average Shares is projected to increase significantly based on the last few years of reporting. The past year's Weighted Average Shares was at 44.74 Million. The current year Issuance Purchase of Equity Shares is expected to grow to about 19.5 K, whereas Weighted Average Shares Diluted is forecasted to decline to about 43.2 M.

Kamada Workforce Comparison

Kamada is rated second overall in number of employees category among related companies. The total workforce of Health Care industry is now estimated at about 209,325. Kamada adds roughly 355 in number of employees claiming only tiny portion of equities under Health Care industry.

Kamada Profit Margins

The company has Profit Margin (PM) of (0.09) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.01) %, which suggests for every $100 dollars of sales, it generated a net operating loss of 0.0.

Kamada Benchmark Summation

The output start index for this execution was zero with a total number of output elements of sixty-one. Kamada Price Series Summation is a cross summation of Kamada price series and its benchmark/peer.

Kamada Notable Stakeholders

A Kamada stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Kamada often face trade-offs trying to please all of them. Kamada's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Kamada's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Gil Efron - CFO, Principal Accounting Officer and Deputy CEOProfile
David Tsur - Co-Founder and Deputy Executive ChairmanProfile
Eran Schenker - Vice President - Medical DirectorProfile
Michal Stein - Vice President and Medical Director for ImmunologyProfile
Shani Dotan - Vice President of Human ResourcesProfile
Yael Brenner - Vice President - QualityProfile
Naveh Tov - Vice President-Clinical Development and Medical Director for Pulmonary DiseasesProfile
Orit Pinchuk - Vice President - Regulatory Affairs and Quality R&DProfile
Eran Schenkar - Vice President - Medical DirectorProfile
Michal Ayalon - Vice President - Research & DevelopmentProfile
Eitan Kyiet - Vice President - Business DevelopmentProfile
Barak Bashari - Sr. VP of OperationsProfile
Ruth Wolfson - Sr. VP of Scientific AffairsProfile
Itzhak Krinsky - DirectorProfile
Tuvia Shoham - DirectorProfile
Abraham Havron - External DirectorProfile
Asaf Frumerman - DirectorProfile
Shmuel Rubinstein - DirectorProfile
Michael Berelowitz - DirectorProfile
Leon Recanati - DirectorProfile
Jonathan Hahn - DirectorProfile
Gwen Melincoff - DirectorProfile
Estery GilozRan - Independent DirectorProfile
Reuven Behar - DirectorProfile
Ziv Kop - DirectorProfile
Pnina Strauss - VP of Clinical Devel. and IPProfile
Liliana Bar - VP of RandDProfile
Eran Nir - Chief OfficerProfile
Hanni Neheman - VP SalesProfile
Ariella Raban - VP HRProfile
Jon Knight - VP OperationsProfile
Chaime Orlev - Chief OfficerProfile
Yifat Esq - Gen LegalProfile
Amir London - Chief OfficerProfile

About Kamada Management Performance

The success or failure of an entity such as Kamada often depends on how effective the management is. Kamada management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Kamada management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Kamada management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for 2022
Return on Average Assets(0.009) (0.009237) 
Return on Average Equity(0.012) (0.0123) 
Return on Invested Capital(0.013) (0.0133) 
Return on Sales(0.015) (0.0154) 
The data published in Kamada's official financial statements usually reflect Kamada's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Kamada. For example, before you start analyzing numbers published by Kamada accountants, it's critical to develop an understanding of what Kamada's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Kamada's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Kamada's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Kamada's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Kamada. Please utilize our Beneish M Score to check the likelihood of Kamada's management to manipulate its earnings.

Kamada Workforce Analysis

Traditionally, organizations such as Kamada use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Kamada within its industry.

Kamada Manpower Efficiency

Return on Kamada Manpower

Revenue Per Employee291.9 K
Revenue Per Executive3 M
Net Loss Per Employee6.3 K
Net Loss Per Executive65.6 K
Working Capital Per Employee162.4 K
Working Capital Per Executive1.7 M
Please see Correlation Analysis. Note that the Kamada information on this page should be used as a complementary analysis to other Kamada's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Kamada Stock analysis

When running Kamada price analysis, check to measure Kamada's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kamada is operating at the current time. Most of Kamada's value examination focuses on studying past and present price action to predict the probability of Kamada's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kamada's price. Additionally, you may evaluate how the addition of Kamada to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Is Kamada's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kamada. If investors know Kamada will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kamada listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
207 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Kamada is measured differently than its book value, which is the value of Kamada that is recorded on the company's balance sheet. Investors also form their own opinion of Kamada's value that differs from its market value or its book value, called intrinsic value, which is Kamada's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kamada's market value can be influenced by many factors that don't directly affect Kamada's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kamada's value and its price as these two are different measures arrived at by different means. Investors typically determine Kamada value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kamada's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.